SCHEMBL631520

SCHEMBL631520

CCC(C)(O)CCC(C)C

nearest known ligand 0.36

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 2/20 0.32
PTPN2 P17706 1/20 0.31
PTPN1 P18031 1/20 0.31
CDC25B P30305 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6758022 1.00 MEN1 (0.36) MEN1CYP3A4ALOX15KMT2AL3MBTL1
SCHEMBL6758018 1.00 MEN1 (0.36) MEN1CYP3A4ALOX15KMT2AL3MBTL1
SCHEMBL21627 0.87 MEN1 (0.44) MEN1CYP3A4ALOX15KMT2AL3MBTL1
SCHEMBL29473918 0.87 MEN1 (0.44) MEN1CYP3A4ALOX15KMT2AL3MBTL1
SCHEMBL9793534 0.87 MEN1 (0.44) MEN1CYP3A4ALOX15KMT2AL3MBTL1
SCHEMBL13280283 0.87 MEN1 (0.44) MEN1CYP3A4ALOX15KMT2AL3MBTL1
SCHEMBL17715626 0.86 MEN1 (0.40) MEN1CYP3A4ALOX15KMT2AL3MBTL1
Potassium SCHEMBL30416076 0.85 MEN1 (0.42) MEN1CYP3A4ALOX15KMT2AL3MBTL1
SCHEMBL30183594 0.85 MEN1 (0.42) MEN1CYP3A4ALOX15KMT2AL3MBTL1
SCHEMBL27501295 0.85 MEN1 (0.42) MEN1CYP3A4ALOX15KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312944-A1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX BASF SE (DE) 2023-10-05 US claimed
EP-4200365-A1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX BASF SE (DE) 2023-06-28 EP claimed
CN-115867614-A UV-curable coating with high refractive index 巴斯夫欧洲公司 2023-03-28 CN claimed
US-20220389245-A1 METAL OXIDE NANOPARTICLES BASF SE (DE) 2022-12-08 US claimed
EP-4031496-A1 METAL OXIDE NANOPARTICLES BASF SE (DE) 2022-07-27 EP claimed
CN-114401927-A Metal oxide nanoparticles 巴斯夫欧洲公司 2022-04-26 CN claimed
WO-2022038161-A1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX BASF SE (DE) 2022-02-24 WO claimed
WO-2021052907-A1 METAL OXIDE NANOPARTICLES BASF SE (DE) 2021-03-25 WO claimed
EP-1878715-B1 Method for obtaining ethanol 3M INNOVATIVE PROPERTIES CO (US) 2013-02-27 EP claimed
EP-1603855-B1 METHOD FOR OBTAINING ETHANOL 3M INNOVATIVE PROPERTIES CO (US) 2008-04-16 EP claimed
EP-1878715-A1 Method for obtaining ethanol 3M Innovative Properties Company (US) 2008-01-16 EP claimed
US-7122709-B2 Method for obtaining ethanol 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-10-17 US claimed
EP-1603855-A1 METHOD FOR OBTAINING ETHANOL 3M Innovative Properties Company (US) 2005-12-14 EP claimed
WO-2004083158-A1 METHOD FOR OBTAINING ETHANOL 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-09-30 WO claimed
US-20040181101-A1 Feeding a solution for extraction using an alkane and alkanol 3M INNOVATIVE PROPERTIES COMPANY 2004-09-16 US claimed
US-20250230374-A1 DUAL-USE COOLANT AND LUBRICANT CUMMINS INC. (US) 2025-07-17 US disclosed
US-20240410055-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2024-12-12 US disclosed
WO-2004083158-A1 METHOD FOR OBTAINING ETHANOL 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-09-30 WO disclosed
US-20040181101-A1 Feeding a solution for extraction using an alkane and alkanol 3M INNOVATIVE PROPERTIES COMPANY 2004-09-16 US disclosed
US-4111917-A POLYURETHANES W. R. GRACE & CO. (US) 1978-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230374-A1 DUAL-USE COOLANT AND LUBRICANT ADH1A, ADH1C, MUC1 MEN1 1881/4885CYP3A4 2305/4885ALOX15 2471/4885
US-20040181101-A1 Feeding a solution for extraction using an alkane and alkanol EBP, GPR3, ADH1C MEN1 1174/4885CYP3A4 1262/4885ALOX15 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.